Preliminary Phase 1 data from Fate Therapeutics indicate that its off-the-shelf CAR T-cell therapy, FT819, can induce early clinical responses in...

Some of the best links we picked up around the internet

Early clinical results suggest that FT836, an off-the-shelf CAR T-cell therapy derived from induced pluripotent stem cells (iPSCs), may induce tumour...

Updated Phase 1 data presented at the 2026 American Society of Gene and Cell Therapy (ASGCT) meeting suggest that Fate Therapeutics’ off-the-shelf CAR...

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet

Some of the best links we picked up around the internet